FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3683811000001102: Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25944701000001111 Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66039601000001117 Negram 500mg tablets (Sanofi) 56 tablet 7 x 8 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Is a Nalidixic acid 500mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Is pack of Negram 500mg tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has active ingredient Nalidixic acid false Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has AMP Negram 500mg tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient Nalidixic acid true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Negram 500mg tablets (Sanofi-Synthelabo Ltd) 56 tablet 7 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start